Navigation Links
MUSC Dedicates New Bioengineering and Drug Discovery Hubs
Date:10/21/2011

CHARLESTON, S.C., Oct. 21, 2011 /PRNewswire-USNewswire/ -- Federal, state and local dignitaries ushered in a new chapter in South Carolina's growing biomedical research effort with the dedication of a laboratory complex designed to speed up cures and treatments for major diseases.

The complex, housing 78 labs and other facilities, signifies a break from the traditional research approach by combining scientists from different fields and allowing them to communicate more effectively. The two buildings – one for bioengineering and one for drug discovery – are interconnected, as are the labs within them. By combining experts from different disciplines in modern facilities with easier access, MUSC hopes to take the science as quickly as possible from the lab to the patient's bedside with improved treatments, medications and medical devices. Cancer, Alzheimer's disease and heart disorders are just some of the medical problems scientists will study in the new complex.

The complex was named after U.S. Rep. James E. Clyburn (D-SC) for his long-standing efforts to correct health disparities in South Carolina and for his support of biomedical research. "My commitment to addressing inequities in our health care system has been a lifelong passion, and it is an important mission here at MUSC. This state-of-the-art research center is evidence of this university's commitment to improving and advancing the delivery of health care, and I am proud to be a part of it," Clyburn said.

Within the center, investigators from numerous MUSC departments share space with scientists, faculty and students from Clemson University and the University of South Carolina. Large auditoria and teleconferencing technologies allow face-to-face interaction with investigators around the world. The center also will promote more partnerships with private industry to help speed up technology transfer and intellectual property commercialization. It will house at least eight of the state-supported SmartState Center of Economic Excellence Endowed Chairs who were recruited to help drive the knowledge-based economy of the state.  The state also played a critical role in funding the construction of the buildings, with half of the cost paid through the Research University Infrastructure Act passed by the S. C. General Assembly in 2004.

"The discoveries coming out of these buildings will enable us to diagnose problems earlier and treat them more effectively, and also will help us to address health disparities that exist in our state. Our hope is that this research center will result in a stronger and more vibrant biomedical community in Charleston and South Carolina," said MUSC President Ray Greenberg.  "If you want to know what our strategic plan for addressing the health needs of this state looks like, just take a look at what will be happening in these two buildings."


'/>"/>
SOURCE Medical University of South Carolina
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. American Oriental Bioengineering Inc. Receives NYSE Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2. American Oriental Bioengineering Reports Second Quarter 2011 Financial Results
3. American Oriental Bioengineering to Announce First Quarter 2011 Financial Results on May 9, 2011
4. American Oriental Bioengineering to Announce Fourth Quarter and Full Year 2010 Financial Results on March 14, 2011
5. American Oriental Bioengineerings CEO and CFO Visit the United States as Entrepreneur Representatives of President Hu Jintaos Delegation
6. American Oriental Bioengineering Introduces Wujia Rongxue Oral Liquid
7. American Oriental Bioengineering to Announce Third Quarter 2010 Financial Results on November 9, 2010
8. American Oriental Bioengineering to Report Second Quarter 2010 Financial Results on August 9, 2010
9. American Oriental Bioengineering Reports Third Quarter 2009 Financial Results
10. American Oriental Bioengineering to Report Third Quarter 2009 Financial Results on November 16, 2009
11. American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... 19, 2017 Companion ... response in pets such as canine, avian and ... various types such as Attenuated Live Vaccines, Conjugate ... Vaccines and Recombinant Vaccines. Attenuated live vaccines are ... bacteria, which have been weakend under laboratory conditions. ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group leased ... is developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company ... life-threatening diseases that have been underserved by scientific ... therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... expanded distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark ... patients with diabetes. The GlycoMark test provides a clinically proven one- to two-week ...
(Date:4/28/2017)... ... 2017 , ... Children and adolescents who enter the foster ... in the general population. That’s because foster care is designed to protect children ... no fault of their own, youth who have experienced trauma often have difficulty ...
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain company ... Tina Howe joined the team, the Bill Howe brand was born and they began ... and giving back to the San Diego community in which they worked, lived and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/27/2017)... ... April 27, 2017 , ... ... respiratory hospital, based in Denver, Colorado, announced an agreement to create the Jane ... continuing support of the Jane and Leonard Korman Family Foundation. The collaboration leverages ...
Breaking Medicine News(10 mins):